Z_Smith , someone texted me your post and asked to
Z_Smith , someone texted me your post and asked to comment..
I hope you don't mind if I do...
We had a very good results in our combo with 350 mg , at efficacy of 81% and not one serious side effect, when other 2 approved drugs were and are 45% efficacy with Maraviroc , and severe side effects , and 43% with every 2 weeks IV treatment with Ibalizumab..
At the same time we started to do higher dose with monotherapy , 525 mg and 700 mg with better results then 350 mg...
And of course FDA wanted to help us , so they asked to do some more patients for safety in mono with 525 mg and 700 mg and they will choose what dose to approve for our combo , since in their opinion we could do better then 81 %...
" you have a great results with 350mg but we see you much better with a higher dose.." .......was said by FDA according to our company..
After FDA delayed us with this for about 9-10 months they chose 700 mg..
And nothing but delays continue.. this was nothing to do with ROT ,
Our study for combo with 350 mg with 81% efficacy was finished in February 2018, and IMO we should be approve then with these results...
And they asked for ROT sometimes October of 2020.
Why , to ask for it few years after study finished no one will ever know, is my opinion...
All imo.
15
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Gathering for a New Kind of Celebration With a buzz louder than a crowded trading floor on a bull day, folks are flocking to catch the ripple effect of "Dedicate." Over 2 million views already, and it hasn't even hit the major radar yet—that's some serious fire in the storytelling world. The premiere in Manila, held at the Missionary Training Center (MTC), was no small...
Continue Reading
Breaking Through Cardiac Barriers Never thought I'd see the day when we're literally sending shockwaves through the heart, but here we are. Abbott's makin' waves, quite literally, with its SonicForce™ Coronary Intravascular Lithotripsy (IVL) System. They’ve just dropped some promising 30-day outcomes from the TECTONIC study, which has grabbed the spotlight at the...
Continue Reading
Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...
Continue Reading
OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...
Continue Reading
What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...
Continue Reading
Afghanistan's Dazzling Triumph Brace ourselves, because what just unfolded in the Hong Kong Sixes 2026 is nothing short of spectacular. Afghanistan's cricket team penned a brand-new chapter in the game's history by overcoming Australia in a pulsating final to capture their maiden Hong Kong Sixes title. Imagine this: chasing a formidable target of 116, they wrapped up the...
Continue Reading
Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...
Continue Reading
UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....
Continue Reading
When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...
Continue Reading
Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...
Continue Reading
Top 5 Most Recently Viewed Articles
Flutter Entertainment Launches New Offering of Senior Secured Notes Flutter Entertainment plc, recognized as a leader in online sports betting and iGaming, has recently announced a significant capital raising initiative. The company is launching an offering of USD-denominated, EUR-denominated, and GBP-denominated senior secured notes that are due in 2031. This news...
Continue Reading
China's Steel Export Boom and Trade Tensions Chinese steel producers are navigating challenging domestic conditions characterized by reduced consumption and ongoing overcapacity. Reports indicate that these manufacturers are expected to continue exporting steel at near-record levels in the coming years, which may intensify existing trade tensions globally. Current Trends...
Continue Reading
Nutanix Short Interest Overview Nutanix, traded under the ticker NTNX, has recently seen its short percent of float decrease by 10.2%. This shift is significant as it highlights a current report showing approximately 5.28 million shares sold short, equating to 2.29% of all trades available for investors. Notably, with the current trading volume, it would take around 3.16...
Continue Reading
The Decline of the Russian Rouble: An Overview The Russian rouble is experiencing significant challenges, having weakened against the U.S. dollar and China's yuan recently. Since early August, the currency has fallen by over 24%, attracting attention from economists and financial analysts alike. Current Market Dynamics As of the latest data, the rouble has reached a...
Continue Reading
NoHo Inc. Expands Strategies for Sustainable Growth NoHo, Inc. (Stock Symbol: DRNK) recently unveiled a series of strategic growth initiatives, marking a pivotal point in the company's journey toward sustainability and innovation. These initiatives are designed to cultivate long-term shareholder value through a multi-faceted approach encompassing new divisions,...
Continue Reading